Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Roche's Roferon-A receives EU approval

March 4, 1997

IGG's MMS-1 covered by patent

March 3, 1997

Immunotherapy cancer vaccine in phase II

Feb. 20, 1997

Encouraging results obtained for immunotoxin in Hodgkin's lymphoma

Feb. 17, 1997

Labeled SMART antibody shows promise for AML treatment

Feb. 17, 1997

Maxim's lead product approaches pivotal trials

Feb. 12, 1997

Genzyme Transgenics reports advances in transgenic production of MAbs

Feb. 11, 1997

Il Yang develops antitumor/immunostimulating proteoglycan

Feb. 7, 1997

AltaRex's lead product given orphan drug status

Jan. 17, 1997

CPMP approves unified labeling for Intron A

Jan. 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...
More than two to tango: multispecifics at ESMO TAT
BioWorld Science
Multispecifics took center stage at this year’s ESMO TAT, emerging as one of the hottest trends in oncology research. Unlike traditional small-molecule drugs or...